Cristina Encinas

1.3k total citations
11 papers, 218 citations indexed

About

Cristina Encinas is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Cristina Encinas has authored 11 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 7 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Cristina Encinas's work include Multiple Myeloma Research and Treatments (6 papers), Peptidase Inhibition and Analysis (4 papers) and Protein Degradation and Inhibitors (3 papers). Cristina Encinas is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Peptidase Inhibition and Analysis (4 papers) and Protein Degradation and Inhibitors (3 papers). Cristina Encinas collaborates with scholars based in Spain, United States and Netherlands. Cristina Encinas's co-authors include Josè Antonio Pérez-Simón, Jesús Martín, Dolores Caballero, Jesús F. San Miguel, María Jesús Rodríguez‐Nieto, Pilar Sánchez-Conde, Ignacio de la Fuente, José Ramón González‐Porras, María Díez‐Campelo and María José Arcos and has published in prestigious journals such as Blood, British Journal of Haematology and Cancers.

In The Last Decade

Cristina Encinas

11 papers receiving 215 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cristina Encinas Spain 6 161 46 36 35 30 11 218
Perla R. Colunga‐Pedraza Mexico 11 182 1.1× 56 1.2× 51 1.4× 76 2.2× 58 1.9× 71 310
Bruno Deltreggia Benites Brazil 9 110 0.7× 66 1.4× 42 1.2× 18 0.5× 104 3.5× 40 237
A Urbano Ispizua Spain 4 121 0.8× 13 0.3× 18 0.5× 36 1.0× 38 1.3× 6 174
Ramzi Jeddi Tunisia 10 115 0.7× 99 2.2× 27 0.8× 77 2.2× 26 0.9× 24 248
Brenda Gibson United Kingdom 8 196 1.2× 93 2.0× 21 0.6× 64 1.8× 42 1.4× 20 305
Mirjam Fechter Netherlands 7 121 0.8× 12 0.3× 12 0.3× 27 0.8× 30 1.0× 15 175
Jaime Oblitas United States 8 154 1.0× 7 0.2× 29 0.8× 58 1.7× 90 3.0× 9 335
PM Ness United States 7 251 1.6× 25 0.5× 47 1.3× 11 0.3× 23 0.8× 11 337
Zefarina Zulkafli Malaysia 10 108 0.7× 39 0.8× 25 0.7× 14 0.4× 82 2.7× 50 208
Emmanouil Nikolousis United Kingdom 8 106 0.7× 17 0.4× 25 0.7× 44 1.3× 17 0.6× 26 174

Countries citing papers authored by Cristina Encinas

Since Specialization
Citations

This map shows the geographic impact of Cristina Encinas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cristina Encinas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cristina Encinas more than expected).

Fields of papers citing papers by Cristina Encinas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cristina Encinas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cristina Encinas. The network helps show where Cristina Encinas may publish in the future.

Co-authorship network of co-authors of Cristina Encinas

This figure shows the co-authorship network connecting the top 25 collaborators of Cristina Encinas. A scholar is included among the top collaborators of Cristina Encinas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cristina Encinas. Cristina Encinas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Ríos, Rafael, Ramón Lecumberri, María Teresa Cibeira, et al.. (2024). A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis. Cancers. 16(9). 1689–1689. 4 indexed citations
3.
White, Darrell, Brea Lipe, Mercedes Gironella, et al.. (2023). OA-41 Iberdomide, bortezomib, and dexamethasone (IberVd) in transplant-ineligible newly diagnosed multiple myeloma (NDMM): results from the CC-220-MM-001 trial. Clinical Lymphoma Myeloma & Leukemia. 23. S25–S25. 3 indexed citations
4.
Hernández‐Rivas, José‐Ángel, Rafael Ríos, Cristina Encinas, Rafael Alonso, & Juan José Lahuerta. (2022). The changing landscape of relapsed and/or refractory multiple myeloma (MM): fundamentals and controversies. Biomarker Research. 10(1). 1–1. 22 indexed citations
5.
Rubia, Javier de la, Bernardo González, Alfonso J. Cruz‐Jentoft, et al.. (2022). Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH study. Journal of Geriatric Oncology. 14(1). 101401–101401. 10 indexed citations
6.
Gómez‐Centurión, Ignacio, M. C. Garcı́a, Eva González-Haba, et al.. (2021). Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility. International Journal of Hematology. 115(1). 61–68. 12 indexed citations
7.
Ríos, Rafael, Noemí Puig, Nuno Barbosa, et al.. (2021). The Current Role of the Heavy/Light Chain Assay in the Diagnosis, Prognosis and Monitoring of Multiple Myeloma: An Evidence-Based Approach. Diagnostics. 11(11). 2020–2020. 5 indexed citations
8.
9.
Caballero‐Velázquez, Teresa, Lucía López‐Corral, Cristina Encinas, et al.. (2013). Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post‐allogeneic transplantation for high‐risk myeloma patients. British Journal of Haematology. 162(4). 474–482. 28 indexed citations
10.
González‐Porras, José Ramón, Ignacio de la Fuente, Josè Antonio Pérez-Simón, et al.. (2008). Prospective evaluation of a transfusion policy of D+ red blood cells into D− patients. Transfusion. 48(7). 1318–1324. 62 indexed citations
11.
Pérez-Simón, Josè Antonio, Cristina Encinas, María José Arcos, et al.. (2008). Prognostic Factors of Chronic Graft-versus-Host Disease Following Allogeneic Peripheral Blood Stem Cell Transplantation: The National Institutes Health Scale Plus the Type of Onset Can Predict Survival Rates and the Duration of Immunosuppressive Therapy. Biology of Blood and Marrow Transplantation. 14(10). 1163–1171. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Perla R. Colunga‐Pedraza Breakdown of academic impact, for papers by Bruno Deltreggia Benites Breakdown of academic impact, for papers by A Urbano Ispizua Breakdown of academic impact, for papers by Ramzi Jeddi Breakdown of academic impact, for papers by Brenda Gibson Breakdown of academic impact, for papers by Mirjam Fechter Breakdown of academic impact, for papers by Jaime Oblitas Breakdown of academic impact, for papers by PM Ness Breakdown of academic impact, for papers by Zefarina Zulkafli Breakdown of academic impact, for papers by Emmanouil Nikolousis
Rankless by CCL
2026